SRRK
NASDAQ · Biotechnology
Scholar Rock Holding Corp
$49.19
+1.86 (+3.93%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+7.71%
1Y
+47.81%
YTD
+14.93%
Open$47.95
Previous Close$47.33
Day High$49.83
Day Low$47.73
52W High$52.19
52W Low$27.07
Volume—
Avg Volume1.26M
Market Cap5.67B
P/E Ratio—
EPS$-3.45
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$45.16
Above
SMA 200
$36.91
Above
RSI (14)
59.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
+44.9% upside
Current
$49.19
$49.19
Target
$71.29
$71.29
$54.07
$71.29 avg
$91.55
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 910.50M | 880.80M | 846.68M |
| Net Income | -11,497,538 | -12,296,426 | -11,692,649 |
| Profit Margin | -1.3% | -1.4% | -1.4% |
| EBITDA | -11,509,292 | -12,212,052 | -11,111,961 |
| Free Cash Flow | -10,999,659 | -14,100,591 | -9,156,076 |
| Rev Growth | +11.0% | +3.4% | +15.4% |
| Debt/Equity | 0.75 | 0.83 | 0.78 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |